Dermatologic and Ophthalmic Drugs Advisory Committee - PDFSEARCH.IO - Document Search Engine

Dermatologic and Ophthalmic Drugs Advisory Committee
Results: 196

#	Item
191	PDF Document Add to Reading List Source URL: www.fda.gov Language: English Clinical research Center for Drug Evaluation and Research United States Department of Health and Human Services Novartis Drug development Dermatologic and Ophthalmic Drugs Advisory Committee Oncology Drug Advisory Committee Pharmaceutical sciences Pharmacology Food and Drug Administration
192	PDF Document Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Center for Drug Evaluation and Research Dermatologic and Ophthalmic Drugs Advisory Committee Oncology Drug Advisory Committee Food and Drug Administration Pharmaceutical sciences Clinical research
193	Microsoft Word - Tables-Where can I go for help.doc Add to Reading List Source URL: www.fda.gov Language: English Medicine Center for Devices and Radiological Health ClinicalTrials.gov Center for Biologics Evaluation and Research Orphan drug Center for Drug Evaluation and Research Dermatologic and Ophthalmic Drugs Advisory Committee Oncology Drug Advisory Committee Food and Drug Administration Clinical research Health
194	Guidance for Industry Advisory Committees: Implementing Section 120 of the Food and Drug Administration Modernization Act of 1997 Add to Reading List Source URL: www.fda.gov Language: English Clinical research Center for Biologics Evaluation and Research Center for Drug Evaluation and Research Committee Dermatologic and Ophthalmic Drugs Advisory Committee Oncology Drug Advisory Committee Food and Drug Administration Medicine Pharmaceutical sciences
195	FR Notice: Drug and Biological Product Consolidation Add to Reading List Source URL: www.fda.gov Language: English Clinical research Center for Biologics Evaluation and Research Center for Drug Evaluation and Research Center for Devices and Radiological Health Medical device Premarket approval Biologic Investigational New Drug Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration Medicine Health
196	Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Briefing Package for sBLA[removed]LUCENTIS (ranibizumab injection) Add to Reading List Source URL: www.fda.gov Language: English Ranibizumab Vascular endothelial growth factor Bevacizumab Macular degeneration Macular edema Genentech Diabetic retinopathy Methadone Macular telangiectasia Medicine Ophthalmology Health